Human pro‐B MLL leukemia cell lines RS4;11 and SEM 34 were purchased from DSMZ. Cells were cultured in Gibco RPMI‐1640 containing 10% FBS at 37°C with 5% CO2 and were maintained between a density of 5 × 105 cells/mL and 2 × 106 cells/mL. The generation of induced drug‐tolerant cells has been described previously. 20 Briefly, naïve cells were exposed to a sublethal dose of bortezomib (5 nmol/L) for 2 wk, replenishing the inhibitor every 3 d. The remaining cells after the treatment were considered as “Tolerant” cells and were collected for analysis. “Reverted” cells were generated from bortezomib‐tolerant cells by culturing without bortezomib for a minimum of 4 wk. All cultured cells were tested for mycoplasma contamination before use.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.